» Authors » Etienne Gignoux

Etienne Gignoux

Explore the profile of Etienne Gignoux including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 26
Citations 248
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Koyuncu A, Asilaza K, Rumunu J, Wamala J, Gitahi P, Antier Z, et al.
PLOS Glob Public Health . 2025 Mar; 5(3):e0003482. PMID: 40048457
In 2021 in response to an outbreak of hepatitis E in Bentiu internally displaced persons camp the South Sudanese Ministry of Health with support from Médecins Sans Frontières implemented the...
2.
Nesbitt R, Kinya Asilaza V, Alvarez C, Gitahi P, Nkemenang P, Duncker J, et al.
Lancet Infect Dis . 2025 Jan; PMID: 39798583
Background: Hepatitis E virus (HEV) is a leading cause of acute viral hepatitis, particularly in Asia and Africa, where HEV genotypes 1 and 2 are prevalent. Although a recombinant vaccine,...
3.
Nesbitt R, Azman A, Kinya Asilaza V, Edwards J, Gitahi P, Nkemenang P, et al.
Lancet Glob Health . 2024 Oct; 12(11):e1881-e1890. PMID: 39424575
Background: Epidemic forms of hepatitis E cause high mortality among pregnant people, with case fatality risks over 30% and adverse fetal outcomes. In 2022, the first mass reactive vaccination campaign...
4.
Meakin S, Nsio J, Camacho A, Kitenge R, Coulborn R, Gignoux E, et al.
Lancet Infect Dis . 2024 Aug; 24(12):1357-1365. PMID: 39178866
Background: The recombinant vesicular stomatitis virus-Zaire Ebola virus (rVSV-ZEBOV) vaccine is the only WHO prequalified vaccine recommended for use to respond to outbreaks of Ebola virus (species Zaire ebolavirus) by...
5.
Gignoux E, Athanassiadis F, Yarrow A, Jimale A, Mubuto N, Deglise C, et al.
PLoS One . 2024 Feb; 19(2):e0299117. PMID: 38354210
[This corrects the article DOI: 10.1371/journal.pone.0260989.].
6.
Coulborn R, Bastard M, Peyraud N, Gignoux E, Luquero F, Guai B, et al.
Lancet Infect Dis . 2024 Feb; 24(6):602-610. PMID: 38340736
Background: The rVSVΔG-ZEBOV-GP vaccine constitutes a valuable tool to control Ebola virus disease outbreaks. This retrospective cohort study aimed to assess the protective effect of the vaccine against death among...
7.
Nesbitt R, Kinya Asilaza V, Gignoux E, Koyuncu A, Gitahi P, Nkemenang P, et al.
PLoS Negl Trop Dis . 2024 Jan; 18(1):e0011661. PMID: 38252655
Introduction: Hepatitis E (HEV) genotypes 1 and 2 are the common cause of jaundice and acute viral hepatitis that can cause large-scale outbreaks. HEV infection is associated with adverse fetal...
8.
Simons E, Nikolay B, Ouedraogo P, Pasquier E, Tiemeni C, Adjaho I, et al.
PLOS Glob Public Health . 2023 Jun; 3(6):e0001457. PMID: 37289736
Although seroprevalence studies have demonstrated the wide circulation of SARS-COV-2 in African countries, the impact on population health in these settings is still poorly understood. Using representative samples of the...
9.
Wagbo Temessadouno F, Ndong J, Gignoux E, Coppieters Y, Ba A, Sidibe Y, et al.
PLOS Glob Public Health . 2023 Mar; 3(1):e0001316. PMID: 36962828
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the virus associated with coronavirus disease (COVID-19). At the time of the study, little data on the level of exposure of the...
10.
Grout L, Katuala Givo Y, Newport T, Mahamat T, Gitahi P, Mandagot J, et al.
Malar J . 2023 Feb; 22(1):44. PMID: 36747229
Background: Angumu health zone in Ituri, Democratic Republic of Congo, is a highly malaria-endemic area with an overburdened health system and hosting internally displaced persons (IDP). The World Health Organization...